How Regure Applies in Pharmaceuticals & Life Sciences
FDA issues new guidance on electronic records, computer system validation, and data integrity for pharmaceutical manufacturing systems. Each guidance update has specific technical implications for systems governed under 21 CFR Part 11. Regure monitors FDA regulatory activity and translates each change into actionable engineering requirements — ensuring pharmaceutical systems remain validated without waiting for an inspection to surface a gap.
Pharmaceutical engagements deploy Regure to maintain continuous awareness of FDA regulatory changes affecting 21 CFR Part 11 validated systems.
Our teams deploy with live regulatory monitoring. When HIPAA, GDPR, UAE PDPL, or FCA frameworks change, Regure flags it and queues the engineering response before the client's legal team finishes reading the announcement.
Healthcare Compliance Frameworks
Regure enforces these frameworks at the infrastructure level across every healthcare engagement. Compliance documentation is generated throughout the build — not assembled before the audit.
Deployed as Part of Every Algorithm Engagement
Regure is not a vendor integration that Algorithm engineers configure for clients. It is embedded infrastructure that ships as part of every relevant engagement. Healthcare organizations that engage Algorithm do not receive a system and a separate compliance tool. They receive a system where Regure is already running — from the first deploy.
Domain: Regulatory Intelligence
Sector: Healthcare
Status: live